AstraZeneca (AZN) reported Q4 earnings Thursday of $0.97 per share, up from $0.62 a year earlier.
Analysts polled by FactSet expected $1.76.
Revenue for the quarter ended Dec. 31 was $14.89 billion, compared with $12.02 billion a year earlier.
Analysts polled by FactSet expected $14.23 billion.
The company said it expected 2025 core earnings per share to increase by a low double-digit percentage. Analysts polled by FactSet expect $9.20.
AstraZeneca also expects revenue growth of a high single-digit percentage for the year. Analysts polled by FactSet expect $56.76 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.